Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Stryker Corp (NY: SYK )

330.18 +4.68 (+1.44%)
Streaming Delayed Price Updated: 2:53 PM EDT, May 7, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Stryker Corp

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
What's Going On With Stryker Stock Today
The orthopedic and surgical device giant Stryker Corporation (NYSE: SYK) stock is trading lower despite reporting Q1 earnings beat and an upbeat outlook. 
Via Benzinga
Stryker Gets Price Target Hikes By Analysts Following Upbeat Q1 Results
Stryker Corporation (NYSE: SYK) reported better-than-expected earnings for its first quarter and increased its full-year profit outlook. 
Via Benzinga
MGM Resorts To Rally Around 33%? Here Are 10 Other Analyst Forecasts For Tuesday
Credit Suisse boosted the price target for KBR, Inc. (NYSE: KBR) from $68 to $71. Credit Suisse analyst Jamie Cook maintained an Outperform rating. KBR shares rose 4.4% to close at $59.16 on Monday. 
Via Benzinga
Pfizer, Ford And 3 Stocks To Watch Heading Into Tuesday
With US stock futures trading mixed this morning on Tuesday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
If You Invested $100 In This Stock 20 Years Ago, You Would Have $900 Today
Via Benzinga
Earnings Preview For Stryker
Via Benzinga
2 Top Stocks to Buy in April and Hold Forever
The need for healthcare goods and/or services is here to stay. 
Via The Motley Fool
The Latest Analyst Ratings for Stryker
Via Benzinga
Should Investors Buy This Dividend Growth Stock?
This medical devices company is already up in 2023. Should you buy it? 
Via The Motley Fool
Earnings Scheduled For May 1, 2023
Companies Reporting Before The Bell • TG Therapeutics (NASDAQ:TGTX) is estimated to report quarterly loss at $0.37 per share on revenue of $3.38 million. 
Via Benzinga
Stryker Expects Good Momentum In 2023 Despite Some Volatility
Via Benzinga
3 Medical Device Stocks Outpacing the Healthcare Industry This Year
All three of these companies have seen double-digit increases in their share prices this year. 
Via The Motley Fool
Global Payments, MGM Resorts And 3 Stocks To Watch Heading Into Monday
With US stock futures trading slightly higher this morning on Monday, some of the stocks that may grab investor focus today are as follows: 
Via Benzinga
These 3 Stocks Might Be Getting a Little Too Expensive
These are promising businesses, but you might want to hold off on buying shares -- for now. 
Via The Motley Fool
Microsoft To Rally Around 9%? Here Are 10 Other Analyst Forecasts For Monday
RBC Capital raised the price target for Pinterest, Inc. (NYSE: PINS) from $26 to $30. RBC Capital analyst Brad Erickson maintained a Sector Perform rating. Pinterest shares gained 1.5% to $27.68 in... 
Via Benzinga
3 Dividend Champions for Long-Term Income
Dividend Champions have grown their dividend payout for at least 25 years in a row. Here are three to keep in mind for long-term income. 
Via InvestorPlace
Here's How Much $1000 Invested In Stryker 20 Years Ago Would Be Worth Today
Via Benzinga
Stryker's Earnings: A Preview
Via Benzinga
Texas Rep. Michael C. Burgess Sold Up to $500K Worth of Stryker Stock
Via Benzinga
Stryker's Debt Overview
Shares of Stryker Inc. (NYSE:SYK) increased by 10.06% in the past three months. When understanding a companies price change over a time period like 3 months, it could be helpful to look at its... 
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 29, 2023
Via Benzinga
Portfolio Highlights: Quarterly Movers & Shakers, March 2023
High quality stocks that generated strong double-digit gains during the past three months. 
Via Talk Markets
BAX: A “Hospital Stock” To Avoid
Baxter International's shares are down nearly 50% over the past three years and have underperformed the broader healthcare industry. 
Via Talk Markets
Interview With David Rolfe of Wedgewood Partners
Motley Fool analyst John Rotonti recently seized the opportunity to interview David Rolfe. 
Via The Motley Fool
Stryker's Q Guidance System Scores FDA Clearance For Cranial Applications
Via Benzinga
General Motors, Bank of America And 2 Other Stocks Insiders Are Selling
The Nasdaq dropped by more than 100 points on Monday. Investors, meanwhile, focused on some notable insider trades. 
Via Benzinga
Price Reversals From Recent Highs In Stocks
Stryker Corp is in a bullish phase on both the daily and weekly charts. Since Friday, the stock had a brick pattern confirmed by Monday’s action. 
Via Talk Markets
Silicon Laboratories, Credit Acceptance, Stryker And Other Big Stocks Moving Higher On Wednesday
U.S. stocks traded lower, with the Dow Jones dropping over 200 points on Wednesday. Here are some big stocks recording gains in today’s session. 
Via Benzinga
Stryker, DaVita And These 2 ETFs: CNBC's 'Final Trades'
On CNBC’s "Halftime Report Final Trades," Liz Young of BNY Mellon Investment Management named the  SPDR S&P Biotech ETF (NYSE: XBI), saying if you "want growth, 
Via Benzinga
Earnings Scheduled For January 31, 2023
Companies Reporting Before The Bell • Biophytis (NASDAQ:BPTS) is projected to report earnings for its first quarter. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.